Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Increased Cefazolin Dosing for C-Section in Obese Women
NCT02049944Phase 4Completed
- Sponsor
- MemorialCare
- Start
- Aug 2013
- Primary completion
- Sep 2014
- Modality
- Reversible Covalent Inhibitors
- Countries
- 1
01
Overview
A Phase 4 trial of cefazolin in surgical site infection (SSI), sponsored by MemorialCare. Started Aug 2013; status: completed.
02
Drugs
cefazolin
03
Conditions
surgical site infection (SSI)
Beyond the preview
Go deeper on NCT02049944.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02049944.